Free Trial
TSE:CRON

Cronos Group (CRON) Stock Price, News & Analysis

Cronos Group logo
C$2.55 -0.02 (-0.78%)
As of 05/2/2025 04:00 PM Eastern

About Cronos Group Stock (TSE:CRON)

Key Stats

Today's Range
C$2.54
C$2.59
50-Day Range
C$2.29
C$2.95
52-Week Range
C$2.27
C$4.28
Volume
31,274 shs
Average Volume
239,830 shs
Market Capitalization
C$673.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$3.54
Consensus Rating
N/A

Company Overview

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Cronos Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

CRON MarketRank™: 

Cronos Group scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cronos Group is -14.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cronos Group is -14.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Cronos Group has a PEG Ratio of 0.12. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Cronos Group has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CRON.
  • Dividend Yield

    Cronos Group does not currently pay a dividend.

  • Dividend Growth

    Cronos Group does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CRON.
  • Search Interest

    2 people have searched for CRON on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cronos Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    46.40% of the stock of Cronos Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.99% of the stock of Cronos Group is held by institutions.

  • Read more about Cronos Group's insider trading history.
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...
Cronos Group price target lowered to $1.65 from $2 at BofA
See More Headlines

CRON Stock Analysis - Frequently Asked Questions

Cronos Group's stock was trading at C$2.89 on January 1st, 2025. Since then, CRON shares have decreased by 11.8% and is now trading at C$2.55.
View the best growth stocks for 2025 here
.

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), NIO (NIO) and Aurora Cannabis (ACB).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:CRON
CIK
N/A
Fax
N/A
Employees
450
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$3.54
High Stock Price Target
C$3.54
Low Stock Price Target
C$3.54
Potential Upside/Downside
+38.8%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
0.12
Net Income
C$-32,779,583.58
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$76.86 million
Cash Flow
C$1.52 per share
Price / Cash Flow
1.67
Book Value
C$2.96 per share
Price / Book
0.86

Miscellaneous

Free Float
N/A
Market Cap
C$673.36 million
Optionable
Not Optionable
Beta
1.02
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (TSE:CRON) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners